Description and Appraisal of Outcome Measures - Clinical Review Report: Eculizumab (Soliris) - NCBI Bookshelf

Price: $ 222.99

4.6(693)

To describe the following outcome measures and review their measurement properties (validity, reliability, responsiveness to change, and MID): Myasthenia Gravis Activities of Daily Living scale (MG-ADL)Quantitative Myasthenia Gravis (QMG) scoreMyasthenia Gravis Composite (MGC) scoreMyasthenia Gravis Quality of Life 15-item scale (MG-QoL15)Myasthenia Gravis Foundation of America Post-Intervention Status (MGFA-PIS)Quality of Life in Neurological Disorders Fatigue Scale (Neuro-QoL Fatigue)European Quality of Life (EuroQol) Health 5-Dimensions (EQ-5D) questionnaire.

https://www.tandfonline.com/cms/asset/41677579-9f07-4df7-92bd-bc69ee26d962/ijme_a_2027706_uf0002_c.jpg

Full article: Quantifying the economic effects of ravulizumab

https://www.ncbi.nlm.nih.gov/books/NBK567515/bin/cl4f7.gif

Clinical Evidence - Clinical Review Report: Eculizumab (Soliris

https://www.ncbi.nlm.nih.gov/books/NBK567405/table/cl4.tab3/?report=thumb

Clinical Evidence - Clinical Review Report: Eculizumab (Soliris

https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-023-01951-3/MediaObjects/41409_2023_1951_Figa_HTML.png

Hematopoietic stem cell transplantation-associated thrombotic

https://www.neurology.org/cms/asset/1fee7026-4773-4a2f-9f0b-a44d77ca2009/wnl.2023.100.issue-9.largecover.jpg

Costs and Utilization of New-to-Market Neurologic Medications

https://www.ncbi.nlm.nih.gov/books/NBK567515/bin/cl4f3.gif

Clinical Evidence - Clinical Review Report: Eculizumab (Soliris

https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs41687-023-00609-4/MediaObjects/41687_2023_609_Fig2_HTML.png

Clinically important change for the FACIT-Fatigue scale in

https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00467-022-05683-2/MediaObjects/467_2022_5683_Fig2_HTML.png

The treatment of atypical hemolytic uremic syndrome with

https://www.ncbi.nlm.nih.gov/books/NBK567515/table/cl4.tab12/?report=thumb

Clinical Evidence - Clinical Review Report: Eculizumab (Soliris

https://www.ncbi.nlm.nih.gov/books/NBK567397/bin/clapp4f2.jpg

Description and Appraisal of Outcome Measures - Clinical Review

https://journals.sagepub.com/cms/10.1177/13524585211038291/asset/images/large/10.1177_13524585211038291-fig1.jpeg

Eculizumab monotherapy for NMOSD: Data from PREVENT and its open

https://www.mdpi.com/brainsci/brainsci-11-01341/article_deploy/html/images/brainsci-11-01341-g002a.png

Brain Sciences, Free Full-Text

https://asset-out-cdn.video-cdn.net/private/videos/-MaJ3C8LsLqhXK1ZgXu2wr/thumbnails/active?quality=1080p&cache-buster=aecd54&__token__=exp=1704232087~acl=/private/videos/-MaJ3C8LsLqhXK1ZgXu2wr/thumbnails/active*~hmac=247e8dac056775efae5e6b9ac642018213100dd1ca6d677cccc69a2d72480324&file-name=1110680.1000.1080p.JPEG

Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome

https://www.ncbi.nlm.nih.gov/books/NBK567409/table/pe3.tab2/?report=thumb

Economic Review - Pharmacoeconomic Report: Eculizumab (Soliris